Yup first FDA approved therapeutic with good safety, efficacy and almost no side effects.
DMC to review interim data within a week or two . If the data is strong, they could recommend to discontinue further trials and proceed right to the FDA for approval.
The entire process could come to a closure in about four to six weeks time frame. We'll see.